Premium
CARDIOTOXICITY RISK IN PATIENTS WITH NON‐HODGKIN LYMPHOMA RECEIVING EPOCH AFTER PRIOR ANTHRACYCLINE EXPOSURE
Author(s) -
Buege M. J.,
Dao P. H.,
Drill E.,
Horwitz S. M.,
LeVoir A.,
Pak T.,
Peterson T. J.,
Matasar M. J.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.193_2880
Subject(s) - medicine , anthracycline , epoch (astronomy) , vincristine , cardiotoxicity , ejection fraction , regimen , etoposide , heart failure , chemotherapy , surgery , oncology , cyclophosphamide , cancer , breast cancer , stars , physics , astronomy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom